Ellevest Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $931K | Sell |
1,853
-90
| -5% | -$43.2K | 0.11% | 133 |
|
|
2026
Q1 | $955K | Sell |
1,943
-212
| -10% | -$115K | 0.13% | 107 |
|
|
2025
Q4 | $1.25M | Sell |
2,155
-95
| -4% | -$53.7K | 0.17% | 81 |
|
|
2025
Q3 | $1.09M | Buy |
2,250
+433
| +24% | +$202K | 0.16% | 98 |
|
|
2025
Q2 | $737K | Buy |
1,817
+272
| +18% | +$114K | 0.12% | 130 |
|
|
2025
Q1 | $769K | Buy |
1,545
+188
| +14% | +$102K | 0.05% | 129 |
|
|
2024
Q4 | $706K | Buy |
1,357
+70
| +5% | +$38.5K | 0.04% | 146 |
|
|
2024
Q3 | $796K | Sell |
1,287
-38
| -3% | -$22.5K | 0.04% | 138 |
|
|
2024
Q2 | $733K | Buy |
1,325
+57
| +4% | +$32.7K | 0.04% | 139 |
|
|
2024
Q1 | $737K | Buy |
1,268
+756
| +148% | +$424K | 0.05% | 141 |
|
|
2023
Q4 | $272K | Buy |
512
+54
| +12% | +$26.1K | 0.02% | 312 |
|
|
2023
Q3 | $232K | Sell |
458
-33
| -7% | -$17.6K | 0.02% | 308 |
|
|
2023
Q2 | $256K | Sell |
491
-74
| -13% | -$39.9K | 0.02% | 295 |
|
|
2023
Q1 | $326K | Sell |
565
-837
| -60% | -$472K | 0.03% | 224 |
|
|
2022
Q4 | $772K | Sell |
1,402
-99
| -7% | -$52.5K | 0.07% | 75 |
|
|
2022
Q3 | $761K | Buy |
1,501
+123
| +9% | +$68.8K | 0.07% | 62 |
|
|
2022
Q2 | $749K | Sell |
1,378
-175
| -11% | -$96.3K | 0.07% | 69 |
|
|
2022
Q1 | $917K | Buy |
1,553
+339
| +28% | +$195K | 0.08% | 60 |
|
|
2021
Q4 | $810K | Buy |
1,214
+28
| +2% | +$17.5K | 0.07% | 64 |
|
|
2021
Q3 | $678K | Sell |
1,186
-16
| -1% | -$8.78K | 0.07% | 72 |
|
|
2021
Q2 | $606K | Buy |
1,202
+195
| +19% | +$92K | 0.06% | 74 |
|
|
2021
Q1 | $460K | Buy |
1,007
+126
| +14% | +$60.1K | 0.06% | 87 |
|
|
2020
Q4 | $410K | Buy |
881
+183
| +26% | +$85.8K | 0.06% | 77 |
|
|
2020
Q3 | $308K | Buy |
698
+113
| +19% | +$46.7K | 0.06% | 94 |
|
|
2020
Q2 | $212K | Buy |
585
+163
| +39% | +$54.6K | 0.05% | 111 |
|
|
2020
Q1 | $120K | Buy |
422
+157
| +59% | +$49.5K | 0.03% | 122 |
|
|
2019
Q4 | $86K | Buy |
265
+163
| +160% | +$49.4K | 0.02% | 120 |
|
|
2019
Q3 | $30K | Buy |
102
+7
| +7% | +$2K | 0.01% | 158 |
|
|
2019
Q2 | $28K | Buy |
95
+55
| +138% | +$15.1K | 0.01% | 179 |
|
|
2019
Q1 | $11K | Hold |
40
| – | – | 0.01% | 187 |
|
|
2018
Q4 | $9K | Buy |
+40
| New | +$9.38K | ﹤0.01% | 387 |
|
Other funds holding TMO
Ellevest Inc's TMO Position: Q2 2026 in Review
Ellevest Inc reduced its Thermo Fisher Scientific (TMO) stake by 4.6% in Q2 2026, selling an estimated $43.2K and leaving 1,853 shares worth $931K. The position accounts for 0.11% of the portfolio, ranked #133.
Ellevest Inc first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.25M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Ellevest Inc held 1,853 shares of Thermo Fisher Scientific worth $931K as of Q2 2026.
- Ellevest Inc sold 90 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.2K.
- Thermo Fisher Scientific made up 0.11% of Ellevest Inc's portfolio in Q2 2026, its #133 holding.
- Ellevest Inc first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- Ellevest Inc's Thermo Fisher Scientific position peaked at $1.25M in Q4 2025.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.